Report predicts burgeoning vaccine markets

Article Abstract:

A prominent consulting firm is predicting that vaccines for diseases like influenza, pneumococcus, HIV and hepatitis C. have the potential to become pharmaceutical profit leaders over the next decade. In order to identify the promising indications, analysts quantified the unmet need for vaccines against specific diseases and the sizes in major pharmaceutical markets, which are Europe, Japan and the United States.

Sales & consumption, Science & research, Pharmaceutical preparations, Research, Pharmaceutical industry, Influence, Virus diseases, Viral vaccines, Market size

---

New class of HIV drugs show promise

Article Abstract:

The new medications developed to fight multi-drug resistant HIV are nearing the clinical trial stage. The analysis of the patients undergoing antiretroviral therapy has demonstrated that the overall prevalence of multi-drug resistance is growing.

Health aspects, Care and treatment, Drugs, Testing, Clinical trials, HIV infection, HIV infections, Drug resistance

---

Shift in NIH focus fuels basic researcher's fears

Article Abstract:

The budget for 2004 for the U. S national institutes of health (NIH) is $28 billion. A strong emphasis on interdisciplinary research is increasing scientists' fear with regard to investigator-driven basic science.

Analysis, United States. National Institutes of Health, Powers and duties, Interdisciplinary research

Similar abstracts:

• Abstracts: Pasko Rakic. Shift in NIH focus fuels basic researcher's fears. US throws money at TSE research
• Abstracts: Tell-tale signs of staffing disaster. Will new rules help overseas nurses? Confronting racism head-on
• Abstracts: Is investment in bioterrorism research warrented? Patents not key barrier to AIDS therapy. New rats set physiologists' hearts aflutter
• Abstracts: NIH posts online ES-cell registry. US to limit AIDS trials in developing nations. Courts crack down on drug marketing strategies

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.